Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.
about
Cardiac gene therapy: are we there yet?Inhibition of cardiac CaMKII to cure heart failure: step by step towards translation?Effect of testosterone supplementation on nitroso-redox imbalance, cardiac metabolism markers, and S100 proteins expression in the heart of castrated male rats.Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease.
P2860
Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cardiomyocytes, endothelial ce ...... ardiovascular pathophysiology.
@en
type
label
Cardiomyocytes, endothelial ce ...... ardiovascular pathophysiology.
@en
prefLabel
Cardiomyocytes, endothelial ce ...... ardiovascular pathophysiology.
@en
P2093
P2860
P356
P1433
P1476
Cardiomyocytes, endothelial ce ...... ardiovascular pathophysiology.
@en
P2093
Anne Volkert
David Rohde
Hugo A Katus
Julia Ritterhoff
Karsten Peppel
Martin Busch
Patrick Most
P2860
P304
P356
10.2217/FCA.15.18
P577
2015-05-01T00:00:00Z